A systematic review was conducted following PRISMA 2020 guidelines. Databases (PubMed, Embase, Scopus, Westlaw, LexisNexis) and gray literature were searched from January 2010 to November 2025 using terms related to medical board discipline, pain management, and overreach. Eligibility included studies, legal cases, and reports on disciplinary actions, due process violations, or consequences for physicians/patients.
Findings of 1,847 records, 42 were included (28 journal articles, eight legal cases, six reports). Key abusive practices included “accuse first, prove later” approaches (18 studies), reliance on unqualified experts (12), and selective evidence of manipulation (10). Impacts included physician burnout and suicide risk (15), financial losses ($50,000 to $500,000; eight), reduced pain fellowship applications (45 percent decline; three), and worsened patient access/opioid crisis (20). The evidence certainty was moderate.
Conclusions and relevance: Medical board overreach in pain medicine is systemic and detrimental. Reforms emphasizing due process and accountability are essential to restore physician trust and improve care.
Medical boards play a critical role in regulating physician practice to protect public safety. However, in pain medicine, particularly amid the opioid crisis, reports suggest boards engage in punitive tactics, such as “creative prosecutions,” that undermine due process and harm health care delivery. This systematic review synthesizes evidence on these practices and their effects.
Imagine dedicating your career to easing the agony of patients who have exhausted every other option, only to find yourself accused, investigated, and potentially stripped of your license not for negligence, but for trying to provide compassionate, evidence-informed care. This is the harsh reality many pain medicine physicians face today, as our systematic review reveals a troubling pattern: Medical board oversight has veered from patient protection toward punitive overreach.
The evidence of overreach
The evidence is consistent and concerning. Practices such as “accuse first, prove later” tactics, reliance on unqualified or conflicted experts, and selective presentation of evidence erode fundamental due process. These are not isolated anecdotes; they appear across 18 sources documenting due process violations and 12 highlighting expert bias. The result? A chilling effect that pushes good doctors out of pain management altogether.
For physicians, the toll is devastating. Financial ruin, often $50,000 to $500,000 in legal fees and lost income, compounds emotional exhaustion. Burnout rates climb (with some studies showing a 3.2-fold increased risk), early retirements surge (up to 22 percent in affected groups), and tragically, suicide ideation and completions rise among those targeted by aggressive investigations. These are not just statistics; they represent dedicated healers broken by a system meant to support them.
Patients bear the heaviest burden. Reduced access to legitimate pain care forces many into desperation, turning to illicit sources, enduring unmanaged suffering, or facing forced tapers that worsen quality of life and, in some cases, contribute to higher overdose risks from street drugs. Our review links these regulatory pressures to a 37 percent drop in opioid prescriptions alongside rising deaths, underscoring how well-intentioned crackdowns can backfire catastrophically.
Why has this shift occurred? The opioid crisis rightly demands accountability, but fear-driven enforcement has created a pendulum swing too far. Boards, pressured by public outcry and federal scrutiny, sometimes prioritize aggressive action over fairness, leaving physicians second-guessing every prescription and patients abandoned in their pain.
Much of the evidence is U.S.-centric (with notable California influence), relies on observational and legal data, and may underreport due to settlement pressures or stigma. Yet the strengths, PRISMA adherence, broad search across databases and gray literature, and moderate GRADE certainty for core findings, make a compelling case that this is a systemic issue, not isolated misconduct.
The path forward
The path forward demands bold, urgent, evidence-based reforms to halt this destructive cycle. Proven models exist and must be scaled nationally. For instance, Texas has implemented stricter probable cause thresholds and innovative programs like “gold-designated practices,” where compliant pain management clinics undergo proactive audits and earn multi-year protections from routine investigations, effectively reducing baseless scrutiny while maintaining safety oversight. These approaches have demonstrably curbed unnecessary cases and restored confidence for ethical prescribers without compromising patient protection.
To go further, states should mandate independent, board-certified experts free of conflicts; require clear probable cause before launching full investigations; provide restitution for physicians exonerated after prolonged probes; and enact penalties for board members or staff engaging in abusive or retaliatory conduct. Transparency must increase through public reporting of case outcomes, standardized evidentiary standards (shifting toward preponderance of evidence where appropriate), and mandatory patient impact considerations balanced with physician due process rights. Above all, boards need structural independence, adequate funding, and training to prioritize proportionality over punishment.
In the end, overreach does not just harm individual doctors; it dehumanizes medicine itself. When healers fear treating pain, patients suffer in silence. It is time for regulators, policymakers, and our profession to demand real balance: robust, fair oversight that safeguards the vulnerable without destroying those who care for them. The stakes, including but not limited to physician well-being, workforce stability, and millions in unrelieved pain, are simply too high to ignore any longer.
Kayvan Haddadan is a physiatrist and pain management physician, and president and medical director of Advanced Pain Diagnostic & Solutions, a multidisciplinary pain management practice in California that he founded in 2012. A physician and surgeon licensed by the Medical Board of California, he is double board-certified in pain medicine and physical medicine and rehabilitation. He is also certified in controlled substance registration through the DEA and serves as a qualified medical examiner through California’s Department of Industrial Relations Division of Workers’ Compensation.
Dr. Haddadan earned his Bachelor of Science degree from the College of Alborz in Tehran, Iran, and his medical degree from Shahid Beheshti University of Medical Sciences. He later received his Educational Commission for Foreign Medical Graduates certification in Philadelphia, completed an internship in medical surgery at Loyola University Medical Center’s Stritch School of Medicine in Illinois, and finished his residency in physical medicine and rehabilitation at the same institution. He completed his fellowship in pain medicine at California Pacific Medical Center’s Pacific Pain Treatment Center and also trained in medical acupuncture for physicians at the University of California, Los Angeles David Geffen School of Medicine.
Dr. Haddadan has contributed to 29 research publications across multiple specialties, including pain management, cardiology, pulmonology, endocrinology, gastroenterology, and infectious disease. His work has examined topics such as hyperlipidemia in high cardiovascular risk patients, hyperuricemia and gout management, type 2 diabetes and hypertension, chronic obstructive pulmonary disease and asthma therapies, influenza treatment, irritable bowel syndrome, and opioid related complications in chronic pain care. His research has also included clinical outcome studies in spinal cord stimulation and award-winning presentations on neuropathic pain management and neuromuscular disorders.
